Trust Company of Vermont’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-5,000
| Closed | -$6K | – | 946 |
|
|
2022
Q3 | $6K | Hold |
5,000
| – | – | ﹤0.01% | 814 |
|
|
2022
Q2 | $5K | Buy |
+5,000
| New | +$5K | ﹤0.01% | 787 |
|
|
2022
Q1 | – | Sell |
-5,000
| Closed | -$7K | – | 618 |
|
|
2021
Q4 | $7K | Buy |
+5,000
| New | +$7K | ﹤0.01% | 701 |
|
|
2021
Q3 | – | Sell |
-5,000
| Closed | -$14K | – | 593 |
|
|
2021
Q2 | $14K | Hold |
5,000
| – | – | ﹤0.01% | 608 |
|
|
2021
Q1 | $19K | Hold |
5,000
| – | – | ﹤0.01% | 561 |
|
|
2020
Q4 | $12K | Hold |
5,000
| – | – | ﹤0.01% | 607 |
|
|
2020
Q3 | $8K | Hold |
5,000
| – | – | ﹤0.01% | 631 |
|
|
2020
Q2 | $9K | Hold |
5,000
| – | – | ﹤0.01% | 638 |
|
|
2020
Q1 | $7K | Hold |
5,000
| – | – | ﹤0.01% | 712 |
|
|
2019
Q4 | $24K | Buy |
+5,000
| New | +$24K | ﹤0.01% | 582 |
|